AICentralResources
AI Tool Comparison

Comparing as AI Medical Research & Clinical Decision Support
Viz.ai vs Abridge

Viz.ai

Viz.ai

VS
Abridge

Abridge

Verdict by Category

Detailed category analysis is not available for this comparison.
View Viz.ai View Abridge

Detailed Comparison

Feature
Viz.ai
Abridge
Pricing
CustomViz.ai operates exclusively on custom enterprise contracts with hospitals, health systems, and imaging networks. There is no published pricing or self-serve access. Pricing is negotiated based on hospital type, imaging volume, number of conditions covered, and multi-site deployment needs. Viz.ai's Medicare NTAP designation provides hospitals with an additional reimbursement of approximately $1,040 per qualifying patient encounter, partially offsetting platform costs. Contact Viz.ai through viz.ai to schedule a demo and begin enterprise procurement discussions.
EnterpriseAbridge does not publish pricing and sells exclusively through enterprise contracts with health systems and hospital groups; there is no self-serve signup or individual-clinician plan. Third-party market analyses and reseller estimates place costs at roughly $200-$800+ per provider per month depending on integration depth (Epic, Oracle Health, or athenahealth), contract scale, and support level, with some estimates for full enterprise rollouts running $600-$1,200+ per provider per month. Implementation typically includes a multi-week to multi-month pilot and IT integration phase before system-wide deployment.
Categories
AI Healthcare ToolsAI Research & Education Tools
AI Healthcare Tools
Summary
AI care coordination platform for stroke, PE, and aortic disease — FDA-cleared algorithms alerting care teams in minutes
Ambient AI that turns clinical conversations into ready-to-sign notes
Viz.ai

Viz.ai Pros & Cons

Pros

  • 12 FDA-cleared algorithms — broadest acute-condition AI portfolio in its class
  • Medicare NTAP reimbursement pathway — unique among AI imaging platforms
  • 44% reduction in DIDO times for stroke patients — peer-reviewed clinical evidence (ISC 2026)
  • 1,000+ hospital deployments across U.S. and Europe
  • Backed by Google Ventures, Kleiner Perkins, and Tiger Global — $289M raised
  • Simultaneous mobile alerts to full care team — no phone-tag delays
  • Expands from neurology to cardiology and pulmonology in one unified platform

Cons

  • Enterprise-only pricing — no self-serve or small clinic access
  • No published pricing — all contracts are custom
  • Primarily focused on acute/time-sensitive conditions — not general radiology reads
  • Requires integration with existing hospital imaging infrastructure
  • Implementation and onboarding take time for large multi-site systems
Abridge

Abridge Pros & Cons

Pros

  • Best in KLAS for Ambient AI two years running (2025 and 2026)
  • Largest independent peer-reviewed study of any ambient AI scribe (NEJM AI, 1,300+ clinicians)
  • Deep, native Epic integration across Haiku, Canto, and Hyperdrive
  • Broad specialty coverage (55+) across outpatient, inpatient, and ED settings
  • Strong enterprise security posture: HIPAA, SOC 2 Type II, ISO 27001

Cons

  • No public pricing, free trial, or self-serve signup for individual clinicians
  • Enterprise-only sales process that can take months to complete
  • Reported documentation error rates (including some hallucinated content) still require clinician review
  • No built-in patient communication, scheduling, or billing automation
  • Not a realistic option for solo practitioners or small group practices

Popular Comparisons

Viz.aivsNabla
Viz.aivsSuki AI
Viz.aivsFreed AI